Drug profile

The FDA adverse-event record for Chlorhexidine + Ketoconazole

26 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Chlorhexidine + Ketoconazole. See the species affected, top reactions, and outcomes below.

26
adverse-event reports
0.0%
death-coded share
Dog
most-reported species
9
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
26
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

ChlorhexidineChlorhexidine + KetoconazoleKetoconazole

Administration Routes

TopicalUnknownAuricular (Otic)

Species Affected

Dog 24
Cat 2

Most Affected Breeds

Shiba Inu 5
Dachshund (unspecified) 4
Shih Tzu 2
Bulldog - French 2
Domestic Shorthair 2
Pekingese 2
Spaniel - Cocker American 2
Terrier - Boston 1
Crossbred Canine/dog 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1

Most Reported Reactions

Vomiting 9
Head tilt - ear disorder 5
Swollen eye 5
Lack of efficacy - NOS 4
Neurogenic keratoconjunctivitis sicca (KCS) 4
Tremor 3
Anorexia 3
Ear infection NOS 3
Corneal ulcer 3
Schirmer tear test 3
Drooping eyelid 3
Nausea 3

Outcome Breakdown

Ongoing
16 (61.5%)
Outcome Unknown
6 (23.1%)
Recovered/Normal
4 (15.4%)

Chlorhexidine + Ketoconazole Adverse Event Insights

26 reports name Chlorhexidine + Ketoconazole; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredients: Chlorhexidine, Chlorhexidine + Ketoconazole, Ketoconazole. Administration routes: Topical, Unknown, Auricular (Otic).

By species: Dog (24 reports), Cat (2 reports). By breed: Shiba Inu (5), Dachshund (unspecified) (4), Shih Tzu (2).

Leading clinical signs: Vomiting (9), Head tilt - ear disorder (5), Swollen eye (5), Lack of efficacy - NOS (4). Outcome, 26 coded reports: Ongoing leads at 61.5%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.